[1]
S. . Subedi, N. . Bahadur Dangi, et A. . Bhattarai, « Adverse Drug Reactions of Potential Antiviral Drugs under Evaluation for the Treatment of COVID-19: Analysis of WHO Global Pharmacovigilance Database », NIJOPHASR, vol. 10, nᵒ 3, p. 17–22, sept. 2021.